BeStock  
Markets › Compare › DNA vs ETRA

DNA vs ETRA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
DNA · Ginkgo Bioworks$7.46 ▼ 9.02%
ETRA · ELECTRA THERAPEUTICS INC$8.11 ▼ 9.28%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4785123160198Sep 18, '26Oct 20, '26Nov 20, '26
  • DNA -5.3%
  • ETRA -38.8%

Head to head

MetricDNAETRA
Price$7.46$8.11
Change today▼ 9.02%▼ 9.28%
Market cap$483.59M$509.85M
Return, 3 months+10.0%–
Return, year to date-10.2%–
Return, 1 year-8.7%–
P/E (TTM)––
P/B1.21.3
P/E percentile vs own 5y30th71st
Dividend yield––
Revenue growth (YoY, latest qtr)-5.7%–
Net profit growth (YoY)+49.2%-150.0%
Gross margin69.8%–
Operating margin-202.5%–
Net margin-192.0%–
Return on equity-52.7%–
Analyst target vs. price-33.0%+302.8%
Analyst buy share0%100%
RSI (14)3743
30-day volatility137.1%96.0%
Max drawdown, 1 year-50.2%-47.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusSellBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ETRA is the largest of the group by market value.
  • ETRA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top